Central indiana Cancer Center

Indianapolis, Indiana 46227

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Human Mammary Carcinoma, Metastatic Breast Cancer, Refractory Cancer

Studies at this site

• PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
• A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine — Completed
• A Phase 1-2, XIAP Antisense AEG35156 With Weekly Paclitaxel in Patients With Advanced Breast Cancer — Stopped early
• A Phase 1-2 XIAP Antisense AEG35156 With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer — Stopped early
• Molecular Profiling Protocol (SCRI-CA-001) — Completed
• Safety and Efficacy of ABT-510 in Subjects With Advanced Renal Cell Carcinoma — Completed